Continuous Glucose Monitoring.
Our portfolio is born from the commitment to offer an integrated ecosystem that accompanies, simplifies, and improves the lives of all people living with diabetes, uniting innovation and precision in every solution.
by providing innovative, comprehensive, and accessible solutions that combine cutting-edge technology, personalized treatments, and a holistic approach to healthcare.
Qardiabetes is a healthcare company committed to transforming the lives of people living with diabetes and cardiovascular conditions. We focus on providing access to innovative, safe, and effective medical devices that empower both patients and healthcare professionals.
Guided by our mission and values, we work hand-in-hand with global partners to deliver trustworthy solutions that are built on compassion, technology, and scientific excellence. From prevention to daily care, Qardiabetes is here.
— From heart to heart.
We combine innovation, empathy, and global collaboration to deliver safe, effective healthcare solutions — always guided by a heart-to-heart connection with those we serve.
At Qardiabetes, we work from heart to heart — with integrity, expertise, and genuine care for every person, every step of the way.
To improve quality of life through trustworthy, accessible medical technology for people living with diabetes and heart conditions.
At Qardiabetes, we believe that great healthcare is built through strong, value-driven partnerships. We proudly collaborate with leading global manufacturers who share our mission of improving the lives of people living with diabetes and cardiovascular conditions.
Each of our partners is carefully selected for their commitment to innovation, reliability, and patient-centered design — ensuring that every solution we offer meets the highest standards of quality and care.
Diabetes is one of the most pressing global health challenges of our time. As of 2024, over 589 million adults worldwide live with diabetes — a figure projected to reach 853 million by 2050. The disease caused 3.4 million deaths in 2024, accounting for 9.3% of all global deaths, and placed a staggering USD 1.015 trillion burden on healthcare systems.
Even more concerning, 1 in 3 adults with diabetes remains undiagnosed, and 1 in 6 pregnancies is affected by high blood sugar. These statistics highlight the urgent need for global action, education, and innovation in diabetes care.
Million people worldwide have diabetes in 2024
Million – Projection 2050
1 in 3 undiagnosed
1 in 6 pregnancies affected
Million deaths annually
Trillion in healthcare spending
Source: IDF Diabetes Atlas, 11th Edition (2025), International Diabetes Federation.
In Latin America, approximately 4 in 10 adults are affected by cardiometabolic syndrome — a growing public health concern driven by rising rates of obesity, sedentary lifestyles, and poor nutrition. Hypertension affects over 35% of the adult population, while overweight and obesity are present in more than two-thirds of adults.
The burden of diabetes alone resulted in over 224,000 deaths in 2024, and healthcare spending related to diabetes reached nearly USD 81 billion, accounting for 8% of global diabetes-related expenses. Projections suggest that without effective interventions, the region will continue facing rising health costs, premature mortality, and deepening inequality.
Source: Pan American Health Organization (PAHO), International Diabetes Federation (IDF), 2025 Latin America Meta-Analysis
of adults affected by cardiometabolic syndrome in Latin America
diabetes-related deaths in Latin America and the Caribbean (2024)
Billions spent on diabetes care in the region (2024)
of adults are overweight or obese
prevalence of hypertension (ages 30–70)
Million adults with diabetes
undiagnosed
cost per person
+ deaths in 2024
In Colombia, more than 3 million adults are living with diabetes — a national prevalence of 8.3%. While progress has been made in diagnosis and awareness, approximately 16.2% of cases remain undiagnosed.
The economic impact is substantial: the average annual healthcare cost per person with diabetes is over USD 1,900, with national spending estimated at nearly USD 5.7 billion. In 2024, the country recorded over 15,000 diabetes-related deaths. These figures emphasize the importance of education, early detection, and equitable access to quality care across the country.
Source: IDF Diabetes Atlas, 11th Edition (2025), International Diabetes Federation.
Purus nibh augue mi dolor. Venenatis lacus faucibus volutpat viverra enim pulvinar lorem turpis nisi. Ipsum cursus elit sit interdum tristique amet. Sagittis turpis diam quis sem. Habitant eget.
Marketing Specialist
Purus nibh augue mi dolor. Venenatis lacus faucibus volutpat viverra enim pulvinar lorem turpis nisi. Ipsum cursus elit sit interdum tristique amet. Sagittis turpis diam quis sem. Habitant eget.
Marketing Specialist
Purus nibh augue mi dolor. Venenatis lacus faucibus volutpat viverra enim pulvinar lorem turpis nisi. Ipsum cursus elit sit interdum tristique amet. Sagittis turpis diam quis sem. Habitant eget.
Marketing Specialist
A new way to support people living with diabetes and cardiovascular conditions.
Sign up now to receive updates about our launch, exclusive insights, and early access to product news. Let’s stay connected — from heart to heart. De corazón a corazón.
